Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform.
Function Oncology has raised $28.0M in total funding. The most recent round was Series A. The last funding was announced in April 2023.
Function Oncology's investors include Andreessen Horowitz, Casdin Capital, S32, Alexandria Venture Investments.
Function Oncology is headquartered in San Diego, United States.
Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform.
Function Oncology is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Function Oncology — Funding & Investors." VCBacked, April 12, 2023, https://www.vcbacked.co/company/function-oncology. Accessed September 30, 2026.
VCBacked. (2023). Function Oncology — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/function-oncology
{{cite web |title=Function Oncology — Funding & Investors |url=https://www.vcbacked.co/company/function-oncology |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated